MedTrace Logo

Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache

NCT01677026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-06-26

No results posted yet for this study

Summary

The primary objectives of the Registry are to:

1. Monitor the transfer of the ATI Neurostimulation System and its safety/clinical performance to a larger number of centers in the post market phase and
2. Collect additional evidence to support reimbursement and clinical acceptance and long term follow up

Conditions

  • Cluster Headache

Sponsors & Collaborators

  • Autonomic Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Arne May, MD, PhD · Institut fur systemische Neurowissenschaften, Universitastsklinikum Hamburg-Eppendorf (UKE)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2018-04-09
Completion
2018-04-09

Countries

  • Denmark
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01677026 on ClinicalTrials.gov